← Back to Search

Education plus game module for Cancer

N/A
Waitlist Available
Led By Justin White, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 56 days after participant's selected quit date (56 to 63 days after enrollment)
Awards & highlights

Study Summary

This study evaluates the effects of a video game embedded in a commercially available mobile application (app) for smoking cessation. Smokers are increasingly turning to mobile health apps for assistance with quitting smoking, and there is a critical need for strategies to engage app users to increase retention and efficacy. Video games are designed to increase users' motivation and engagement, which in turn may increase their exposure and adherence to a smoking cessation program. The hypothesis is that the game increases engagement, retention, and smoking abstinence rates compared with a core version of the app without the game. A two-arm individually randomized pilot trial of 500 adult smokers will test this hypothesis, comparing outcomes for participants randomized to receive the core app plus embedded game with participants randomized to receive the core app only. Primary outcomes relate to user engagement with the app. Secondary outcomes relate to user engagement, efficacy (smoking abstinence), and user satisfaction.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~56 days after participant's selected quit date (56 to 63 days after enrollment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 56 days after participant's selected quit date (56 to 63 days after enrollment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Minutes of App Usage Per Session
Number of Unique App Sessions
Secondary outcome measures
Satisfaction With App
Satisfaction With Game (Intervention Group Only)
Self-reported 30-day Point-prevalence Abstinence at 2 Months
+2 more
Other outcome measures
Biochemically Verified 30-day Point-prevalence Abstinence at 2 Months
Biochemically Verified 7-day Point-prevalence Abstinence at 2 Months
Digital Therapeutic Alliance
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Education plus game moduleExperimental Treatment2 Interventions
Participants receive an educational intervention through the Smoke Free application with the embedded game module. Participants complete questionnaires and may undergo saliva sample collection, if they report being smoke-free on follow-up.
Group II: Education module onlyActive Control1 Intervention
Participants receive an educational intervention through the Smoke Free application only (core app only). Participants complete questionnaires and may undergo saliva sample collection, if they report being smoke-free on follow-up.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Game Module
2022
N/A
~500
Smoke Free smartphone application
2022
N/A
~500

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,506 Previous Clinical Trials
15,238,055 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,665 Previous Clinical Trials
40,925,354 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,020,425 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~158 spots leftby Apr 2025